Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | FDPS | P14324 | 11/20 | 0.33 |
| ▸ | GGPS1 | O95749 | 7/20 | 0.33 |
| ▸ | LSS | P48449 | 1/20 | 0.32 |
| ▸ | SMPD1 | P17405 | 2/20 | 0.31 |
| ▸ | CES2 | O00748 | 1/20 | 0.31 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.31 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10712746 | 0.97 | TSHR (0.40) | TSHRTHRBFDPSGGPS1SMPD1 | |
| SCHEMBL23084849 | 0.97 | TSHR (0.40) | TSHRTHRBFDPSGGPS1SMPD1 | |
| SCHEMBL21291788 | 0.97 | TSHR (0.40) | TSHRTHRBFDPSGGPS1SMPD1 | |
| SCHEMBL4246433 | 0.95 | TSHR (0.38) | TSHRTHRBFDPSGGPS1SMPD1 | |
| SCHEMBL7940705 | 0.82 | DNM1 (0.35) | TSHRTHRBFDPSGGPS1SMPD1 | |
| SCHEMBL30291001 | 0.80 | DNM1 (0.44) | TSHRTHRBFDPSGGPS1CES2 | |
| SCHEMBL23084856 | 0.80 | DNM1 (0.39) | TSHRTHRBFDPSGGPS1SMPD1 | |
| SCHEMBL22436204 | 0.79 | TSHR (0.35) | TSHRTHRBFDPSGGPS1SMPD1 | |
| SCHEMBL21179492 | 0.79 | TSHR (0.42) | TSHRTHRBFDPSGGPS1SMPD1 | |
| SCHEMBL18722279 | 0.79 | TSHR (0.42) | TSHRTHRBFDPSGGPS1SMPD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090087753-A1 | VOLUME PHASE HOLOGRAM RECORDING MATERIAL, PRODUCTION PROCESS THEREFOR, AND RECORDED MATERIAL | TOAGOSEI CO., LTD. (JP) | 2009-04-02 | — | — | US | claimed |
| EP-1906265-A1 | VOLUME PHASE HOLOGRAM RECORDING MATERIAL, PROCESS FOR PRODUCING THE SAME, AND RECORDED MATERIAL | TOAGOSEI CO., LTD. (JP) | 2008-04-02 | — | — | EP | claimed |
| US-9944765-B2 | Curable compositions and membranes | FUJIFILM MANUFACTURING EUROPE B.V. (NL) | 2018-04-17 | — | — | US | disclosed |
| EP-3007809-B1 | CURABLE COMPOSITIONS AND MEMBRANES | FUJIFILM MFG EUROPE BV (NL) | 2017-10-18 | — | — | EP | disclosed |
| EP-3137522-A1 | CURABLE COMPOSITIONS AND MEMBRANES | Fujifilm Manufacturing Europe BV (NL) | 2017-03-08 | — | — | EP | disclosed |
| US-20170037206-A1 | Curable Compositions and Membranes | FUJIFILM MANUFACTURING EUROPE B.V. (NL) | 2017-02-09 | — | — | US | disclosed |
| US-9556316-B2 | Curable compositions and membranes | FUJIFILM MANUFACTURING EUROPE B.V. (NL) | 2017-01-31 | — | — | US | disclosed |
| US-20160137797-A1 | Curable Compositions and Membranes | FUJIFILM MANUFACTURING EUROPE B.V. (NL) | 2016-05-19 | — | — | US | disclosed |
| EP-3007809-A1 | CURABLE COMPOSITIONS AND MEMBRANES | Fujifilm Manufacturing Europe BV (NL) | 2016-04-20 | — | — | EP | disclosed |
| WO-2015166213-A1 | CURABLE COMPOSITIONS AND MEMBRANES | FUJIFILM MANUFACTURING EUROPE BV (NL) | 2015-11-05 | — | — | WO | disclosed |
| WO-2014199125-A1 | CURABLE COMPOSITIONS AND MEMBRANES | FUJIFILM MANUFACTURING EUROPE BV (NL) | 2014-12-18 | — | — | WO | disclosed |
| US-7208451-B2 | IMS detection of chemical markers in petroleum products | AUTHENTIC INC. (US) | 2007-04-24 | — | — | US | disclosed |
| EP-1253140-B1 | PROCESS FOR CYCLIZING OPTICALLY ACTIVE 4-AMINO-2-HALOGENOBUTYRIC ACIDS | KANEKA CORP (JP) | 2005-01-12 | — | — | EP | disclosed |
| US-20040147413-A1 | IMS detection of chemical markers in petroleum products | AUTHENTIX, INC. | 2004-07-29 | — | — | US | disclosed |
| US-6747161-B2 | AZETIDINE-2-CARBOXYLIC ACID; ALKALINE EARTH METAL OXIDE OR HYDROXIDE, OR AMINE; HIGH OPTICAL YIELD | KANEKA CORPORATION (JP) | 2004-06-08 | — | — | US | disclosed |
| US-20030109719-A1 | Process for cyclizing optically active 4-amino-2-halogenobutyric acids | SAKA YASUHIRO (JP) | 2003-06-12 | — | — | US | disclosed |
| EP-1253140-A1 | PROCESS FOR CYCLIZING OPTICALLY ACTIVE 4-AMINO-2-HALOGENOBUTYRIC ACIDS | KANEKA CORPORATION (JP) | 2002-10-30 | — | — | EP | disclosed |
| US-6248885-B1 | 1. TERT-OCTYLDI-N-PROPLYLAMINE. 2. TERT-OCTYL-N-MORPHOLINE-BORANE. | SIGMA-ALDRICH CO. | 2001-06-19 | — | — | US | disclosed |
| US-4361695-A | Polyesters of N,N-di-alkanol-amines with di-(hydroxy-alkyl-benzyl) malonic acids and use thereof as stabilizers for polymers | MONTEDISON S.P.A. (IT) | 1982-11-30 | — | — | US | disclosed |
| EP-0031424-A1 | Polyesters of N,N-di-alkanol-amines with di-(hydroxy-alkyl-benzyl)malonic acids, and compositions containing same as stabilizers | Montedison S.p.A. (IT) | 1981-07-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030109719-A1 | Process for cyclizing optically active 4-amino-2-halogenobutyric acids | AOC2, AZI2, ALAD | TSHR 827/4885THRB 792/4885FDPS 2519/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.